Skip to main content
. 2019 Oct 25;22(11):1410–1416. doi: 10.1089/jpm.2019.0088

Table 1.

Sample Characteristics by Treatment Group (N = 23)

  SPIRIT in person (n = 12) SPIRIT remote (n = 11)
Characteristics PWD Surrogate PWD Surrogate
Age in years, M (SD) 73.7 (7.5) 63.1 (11.8) 74.7 (7.9) 69.7 (9.8)
Female, n (%) 7 (58.3) 8 (66.7) 5 (41.7) 7 (63.6)
Years of formal education completed 15.4 (2.5) 16.6 (2.7) 15.2 (3.0) 16.3 (2.3)
White (non-Hispanic) 9 (75.0) 9 (75.0) 8 (72.7) 9 (81.8)
Relationship to PWD
 Spouse/partner 8 (66.7) 9 (81.8)
 Child 4 (33.3) 2 (18.2)
Have had a close family member or friend die 12 (100.0) 12 (100.0) 10 (90.9) 10 (90.9)
Had a discussion with PWD about his/her wishes
 With PWD alone only 7 (58.3) 7 (63.6)
 With PWD and his/her doctor 4 (33.3) 4 (36.4)
Dementia type
 Alzheimer's disease 10 (83.3) 8 (72.7)
 Lewy bodies 2 (16.7) 0
 Vascular 0 1 (9.1)
 Frontotemporal 0 1 (9.1)
 Mixed 0 1 (9.1)
Months since dementia diagnosis, M (SD) 38.8 (27.8) 31.1 (17.0)
Recent global cognitive function (MoCA score), M (SD), range 17.1 (2.9) (14–25) 18.3 (5.0) (13–25)
Months since last MoCA 4.7 (6.2) (0–22) 8.5 (9.5) (0–32)
Top 3 comorbid conditions, n (%)
 Hypertension 7 (58.3) 6 (54.6)
 Depression 6 (50.0) 6 (54.5)
 Diabetes 2 (16.7) 3 (27.3)
UBACC score at enrollment, M (SD), range 13.1 (2.0) (10–16) 13.3 (2.3) (9–16)

MoCA, Montreal Cognitive Assessment; PWD, person with dementia; SD, standard deviation; SPIRIT, Sharing Patient's Illness Representations to Increase Trust; UBACC, University of California San Diego Brief Assessment of Capacity to Consent.